{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T14:05:03Z","timestamp":1773065103978,"version":"3.50.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T00:00:00Z","timestamp":1576108800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T00:00:00Z","timestamp":1576108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Higher Education Centre of Excellence (HICoE) special funding","award":["311\/CDADAH\/4401009"],"award-info":[{"award-number":["311\/CDADAH\/4401009"]}]},{"name":"USM Short Term Research Grant","award":["304\/CDADAH\/6315105"],"award-info":[{"award-number":["304\/CDADAH\/6315105"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s00213-019-05418-6","type":"journal-article","created":{"date-parts":[[2020,2,22]],"date-time":"2020-02-22T09:02:46Z","timestamp":1582362166000},"page":"855-867","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Assessing physiological dependence and withdrawal potential of mitragynine using schedule-controlled behaviour in rats"],"prefix":"10.1007","volume":"237","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7040-675X","authenticated-orcid":false,"given":"Norsyifa","family":"Harun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Illa Syafiqah","family":"Johari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharif Mahsufi","family":"Mansor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Shoaib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,12]]},"reference":[{"issue":"4","key":"5418_CR1","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/BF02243995","volume":"100","author":"JU Adams","year":"1990","unstructured":"Adams JU, Holtzman SG (1990) Tolerance and dependence after continuous morphine infusion from osmotic pumps measured by operant responding in rats. Psychopharmacology 100(4):451\u2013458","journal-title":"Psychopharmacology"},{"key":"5418_CR2","first-page":"67","volume-title":"Testing and evaluation of drugs of abuse","author":"MD Aceto","year":"1990","unstructured":"Aceto MD (1990) Assessment of physical dependence techniques for the evaluation of abused drugs. In: Adler MW, Cowan A (eds) Testing and evaluation of drugs of abuse. Wiley-Liss, New York, pp 67\u201379"},{"key":"5418_CR3","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jep.2012.03.009","volume":"141","author":"K Ahmad","year":"2012","unstructured":"Ahmad K, Aziz Z (2012) Mitragyna speciosa use in the northern states of Malaysia: a cross-sectional study. J Ethnopharmacol 141:446\u2013450","journal-title":"J Ethnopharmacol"},{"issue":"3","key":"5418_CR4","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.pbb.2012.01.024","volume":"101","author":"XF An","year":"2012","unstructured":"An XF, Zhang Y, Winter JC, Li JX (2012) Effects of imidazoline I2 receptor agonists and morphine on schedule-controlled responding in rats. Pharmacol Biochem Behav 101(3):354\u2013359","journal-title":"Pharmacol Biochem Behav"},{"key":"5418_CR5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s002130100793","volume":"157","author":"T Anraku","year":"2001","unstructured":"Anraku T, Ikegaya Y, Matsuki N, Nishiyama N (2001) Withdrawal from chronic morphine administration causes prolonged enhancement of immobility in rat forced swimming test. Psychopharmacology 157:217\u2013220","journal-title":"Psychopharmacology"},{"key":"5418_CR6","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1080\/10826080701205869","volume":"42","author":"S Assanangkornchai","year":"2007","unstructured":"Assanangkornchai S, Muekthong A, Sam-Angsri N, Pattanasattayawong U, Takayama H (2007) The use of Mitragyna speciosa (\u201cKrathom\u201d), an addictive plant, in Thailand. Subst Use Misuse 42:2145\u20132157","journal-title":"Subst Use Misuse"},{"key":"5418_CR7","first-page":"403","volume-title":"Behavioural pharmacology; the current status. Neurology and neurobiology","author":"RL Balster","year":"1985","unstructured":"Balster RL (1985) Behavioural studies of tolerance and dependence. In: Seidin LS, Balster RL (eds) Behavioural pharmacology; the current status. Neurology and neurobiology, vol 13. Liss, New York, pp 403\u2013418"},{"issue":"1","key":"5418_CR8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0014-2999(99)00792-X","volume":"387","author":"PM Beardsley","year":"2000","unstructured":"Beardsley PM, Martin BR (2000) Effects of the cannabinoid CB1 receptor antagonist, SR141716A, after \u03949-tetrahydrocannabinol withdrawal. Eur J Pharmacol 387(1):47\u201353","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"5418_CR9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00213-009-1773-3","volume":"209","author":"GL Becker","year":"2010","unstructured":"Becker GL, Gerak LR, Li J, Koek W, France CP (2010) Precipitated and conditioned withdrawal in morphine-treated rats. Psychopharmacology 209(1):85\u201394","journal-title":"Psychopharmacology"},{"issue":"6","key":"5418_CR10","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1360-0443.2008.02209.x","volume":"103","author":"EW Boyer","year":"2008","unstructured":"Boyer EW, Babu KM, Adkins JE, McCurdy CR, Halpern JH (2008) Self-treatment of opioid withdrawal using kratom (Mitragyna speciosa korth). Addiction 103(6):1048\u20131050","journal-title":"Addiction"},{"key":"5418_CR11","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.phymed.2015.07.008","volume":"22","author":"D Cheaha","year":"2017","unstructured":"Cheaha D, Kewapradub N, Sawangjaroen K, Phukpattaranont P, Kumarnist E (2017) Effects of an alkaloid-rich extract from Mitragyna speciosa leaves and fluoxetine on sleep profiles, EEG spectral frequency and ethanol withdrawal symptoms in rats. Phytomed 22:1000\u20131008","journal-title":"Phytomed"},{"key":"5418_CR12","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1124\/jpet.108.139196","volume":"326","author":"ZD Cooper","year":"2008","unstructured":"Cooper ZD, Troung YN, Shi YG, Woods JH (2008) Morphine deprivation increases self-administration of the fast- and short- acting mu-opioid receptor agonist remifentanil in the rat. J Pharmacol Exp Ther 326:920\u2013929","journal-title":"J Pharmacol Exp Ther"},{"key":"5418_CR13","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00213-010-1966-9","volume":"212","author":"ZD Cooper","year":"2010","unstructured":"Cooper ZD, Shi YG, Woods JH (2010) Reinforcer-dependent enhancement of operant responding in opioid withdrawn rats. Psychopharmacology 212:369\u2013378","journal-title":"Psychopharmacology"},{"issue":"2","key":"5418_CR14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.drugalcdep.2005.05.009","volume":"81","author":"WM Compton","year":"2006","unstructured":"Compton WM, Volkow ND (2006) Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend 81(2):103\u2013107","journal-title":"Drug Alcohol Depend"},{"issue":"2\u20133","key":"5418_CR15","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1054\/plef.2001.0360","volume":"66","author":"E Fride","year":"2002","unstructured":"Fride E (2002) Endocannabinoids in the central nervous system- an overview. Prostaglandins Leukot Essent Fatty Acids 66(2\u20133):221\u2013233","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"5418_CR16","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0091-3057(76)90199-4","volume":"4","author":"RD Ford","year":"1976","unstructured":"Ford RD, Balster RL (1976) Schedule-controlled behaviour in the morphine-dependent rat. Pharmacol Biochem Behav 4:569\u2013573","journal-title":"Pharmacol Biochem Behav"},{"key":"5418_CR17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF00439441","volume":"97","author":"SR Goldberg","year":"1989","unstructured":"Goldberg SR, Risner ME, Stolerman IP, Reavill C, Garcha HS (1989) Nicotine and some related compounds: effects on schedule-controlled behaviour and discriminative properties in rats. Psychopharmacology 97:295\u2013302","journal-title":"Psychopharmacology"},{"key":"5418_CR18","doi-asserted-by":"crossref","first-page":"4,713","DOI":"10.1517\/14656566.5.4.713","volume":"5","author":"G Gonzalez","year":"2004","unstructured":"Gonzalez G, Oliveto A, Kosten TR (2004) Combating opiate dependence: a comparison among the available pharmacological options. Expert Opin Pharmacother 5:4,713\u20134,725","journal-title":"Expert Opin Pharmacother"},{"key":"5418_CR19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.drugalcdep.2017.03.007","volume":"176","author":"O Grundmann","year":"2017","unstructured":"Grundmann O (2017) Patterns of kratom use and health impact in the US-results from an online survey. Drug Alcohol Depend 176:63\u201370","journal-title":"Drug Alcohol Depend"},{"key":"5418_CR20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pbb.2015.08.003","volume":"137","author":"BW Gunter","year":"2015","unstructured":"Gunter BW, Platt DM, Rowlett JK (2015) Differential interactions engendered by benzodiazepine and neuroactive steroid combinations on schedule-controlled responding in rats. Pharm Biochem and Behav 137:53\u201359","journal-title":"Pharm Biochem and Behav"},{"issue":"13","key":"5418_CR21","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1007\/s00213-015-3866-5","volume":"232","author":"N Harun","year":"2015","unstructured":"Harun N, Hassan Z, Navaratnam V, Mansor SM, Shoaib M (2015) Discriminative stimulus properties of mitragynine (kratom) in rats. Psychopharmacology 232(13):2227\u20132238","journal-title":"Psychopharmacology"},{"issue":"2","key":"5418_CR22","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.neubiorev.2012.11.012","volume":"37","author":"Z Hassan","year":"2013","unstructured":"Hassan Z, Muzaimi M, Navaratnam V, Yusoff NH, Suhaimi FW, Vadivelu R, Vicknasingam BK, Amato D, von H\u00f6rsten S, Ismail NI, Jayabalan N, Hazim AI, Mansor SM, M\u00fcller CP (2013) From kratom to mitragynine and its derivatives: physiological and behavioural effects related to use, abuse and addiction. Neurosci Biobehav Rev 37(2):138\u2013151","journal-title":"Neurosci Biobehav Rev"},{"issue":"5","key":"5418_CR23","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1111\/adb.12639","volume":"24","author":"Scott E. Hemby","year":"2018","unstructured":"Hemby SE, McIntosh S, Leon F, Cutler SJ, McCurdy CR (2018) Abuse liability and therapeutic potential of the Mitragyna speciosa (kratom) alkaloids mitragynine and 7-hydroxymitragynine. Addict Biol. https:\/\/doi.org\/10.1111\/adb.12639","journal-title":"Addiction Biology"},{"key":"5418_CR24","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1007\/s00213-019-05247-7","volume":"236","author":"T Hiranita","year":"2019","unstructured":"Hiranita T, Leon F, Felix JS, Rastrepo LF, Reeves ME, Pennington AE, Obeng S, Avery BA, McCurdy CR, McMahon LR, Wilkerson JL (2019) The effects of mitragynine and morphine on scheduled-controlled responding and antinociception in rats. Psychopharmacology 236:2725\u20132734. https:\/\/doi.org\/10.1007\/s00213-019-05247-7","journal-title":"Psychopharmacology"},{"issue":"4","key":"5418_CR25","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/adb.12385","volume":"22","author":"NIW Ismail","year":"2017","unstructured":"Ismail NIW, Jayabalan N, Mansor SM, Muller CP, Muzaimi M (2017) Chronic mitragynine (kratom) enhances punishment resistance in natural reward seeking and impairs place learning in mice. Addict Biol 22(4):967\u2013976","journal-title":"Addict Biol"},{"key":"5418_CR26","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.drugalcdep.2017.06.033","volume":"179","author":"JD Jones","year":"2017","unstructured":"Jones JD, Manubay JM, Mogali S, Metz VE, Madera G, MartinezS MM, Comer SD (2017) Abuse liability if intravenous buprenorphine vs. buprenorphine\/naloxone: importance of absolute naloxone amount. Drug Alcohol Depend 179:362\u2013369","journal-title":"Drug Alcohol Depend"},{"issue":"12","key":"5418_CR27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028340","volume":"6","author":"B Khor","year":"2011","unstructured":"Khor B, Jamil S, Adenan MFA, Adenan MI, Shu-Chien AC (2011) Mitragynine attenuates withdrawal syndrome in morphine-withdrawn zebrafish. PLoS One 6(12):e28340","journal-title":"PLoS One"},{"key":"5418_CR28","doi-asserted-by":"crossref","first-page":"6754","DOI":"10.1021\/jacs.6b00360","volume":"138","author":"AC Kruegel","year":"2016","unstructured":"Kruegel AC, Gassaway MM, Kapoor A, Varadi A, Majumdar S, Filizola M (2016) Synthetic and receptor signaling explorations of the Mitragyna alkaloids: mitragynine as an atypical molecular framework for opioid receptor modulators. J American Chem Soc 138:6754\u20136764","journal-title":"J American Chem Soc"},{"issue":"1","key":"5418_CR29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.pbb.2010.04.011","volume":"96","author":"X Li","year":"2010","unstructured":"Li X, Li JX, France CP (2010) Interactions between morphine, scopolamine and nicotine: schedule-controlled responding in rats. Pharmacol Biochem Behav 96(1):91\u201395","journal-title":"Pharmacol Biochem Behav"},{"key":"5418_CR30","first-page":"1007","volume":"298","author":"AH Lichtman","year":"2001","unstructured":"Lichtman AH, Sheikh SM, Loh HH, Martin BR (2001) Opioid and cannabinoid modulation of precipitated withdrawal in \u03949-Tetrahydrocannabinol and morphine-dependent mice. J Pharmacol Exp Ther 298:1007\u20131041","journal-title":"J Pharmacol Exp Ther"},{"key":"5418_CR31","first-page":"145","volume":"198","author":"E Macko","year":"1972","unstructured":"Macko E, Weisbach JA, Douglas B (1972) Some observations on the pharmacology of mitragynine. Arch Int de Pharmacodynamieet de Therapie 198:145\u2013161","journal-title":"Arch Int de Pharmacodynamieet de Therapie"},{"key":"5418_CR32","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0163-7258(02)00254-1","volume":"95","author":"R Maldonado","year":"2002","unstructured":"Maldonado R (2002) Study of cannabinoid dependence in animals. Pharmacol Ther 95:153\u2013164","journal-title":"Pharmacol Ther"},{"issue":"4","key":"5418_CR33","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.tins.2006.01.008","volume":"29","author":"R Maldonado","year":"2006","unstructured":"Maldonado R, Valverde O, Berrendero F (2006) Involvement of the endocannabinoid system in drug addiction. Trends Neurosci 29(4):225\u2013232","journal-title":"Trends Neurosci"},{"key":"5418_CR34","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/0024-3205(96)00432-8","volume":"59","author":"K Matsumoto","year":"1996","unstructured":"Matsumoto K, Mizowaki M, Suchitra T, Takayama H, Sakai S, Aimi N, Watanabe H (1996) Antinociceptive action of mitragynine in mice: evidence for the involvement of supraspinal opioid receptors. Life Sci 59:1149\u20131155","journal-title":"Life Sci"},{"issue":"1","key":"5418_CR35","first-page":"1","volume":"1","author":"J Nanthini","year":"2015","unstructured":"Nanthini J, Ismail NIW, Mansor SM, Muller CP, Muzaimi M (2015) Cerebellum and endocannabinoid receptors: a new possible neurobiological link for mitragynine (Mitragyna speciosa Korth) abuse liability. J Addict Depend 1(1):1\u20137","journal-title":"J Addict Depend"},{"key":"5418_CR36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"AB Nair","year":"2016","unstructured":"Nair AB, Jacob S (2016) A simple practice guide for dose conversion between animals and human. J Basic Clin Pharma 7:27\u201331","journal-title":"J Basic Clin Pharma"},{"key":"5418_CR37","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1097\/00001756-199810260-00012","volume":"9","author":"M Navarro","year":"1998","unstructured":"Navarro M, Chowen J, Carrera MRA, del Arco I, Villanua MA, Martin Y, Robert AJ, Koob GF, de Fonseca FR (1998) CB1 cannabinoid receptor antagonist induced opiate withdrawal in morphine-dependent rats. Neuroreport 9:3397\u20133402","journal-title":"Neuroreport"},{"key":"5418_CR38","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.drugalcdep.2015.02.021","volume":"150","author":"J Palma","year":"2015","unstructured":"Palma J, Abood ME, Benamar K (2015) HIV-gp120 and physical dependence to buprenorphine. Drug Alcohol Depend 150:175\u2013178","journal-title":"Drug Alcohol Depend"},{"issue":"12","key":"5418_CR39","first-page":"792","volume":"112","author":"WC Prozialeck","year":"2012","unstructured":"Prozialeck WC, Jivan JK, Andurkar SV (2012) Pharmacology of kratom: an emerging botanical agent with stimulant, analgesic and opioid-like effects. J Am Osteopath Assoc 112(12):792\u2013799","journal-title":"J Am Osteopath Assoc"},{"key":"5418_CR40","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1055\/s-2006-959578","volume":"60","author":"D Ponglux","year":"1994","unstructured":"Ponglux D, Wongseripipatana S, Takayama H, Kikuchi M, Kurihara M, Kitajima M, Aimi N, Sakai S (1994) A new indole alkaloid, 7alpha-hydroxy-7H-mitragynine, from Mitragyna speciosa in Thailand. Planta Med 60:580\u2013581","journal-title":"Planta Med"},{"key":"5418_CR41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/ddr.21052","volume":"74","author":"A Sabetghadam","year":"2013","unstructured":"Sabetghadam A, Navaratnam V, Mansor SM (2013) Dose-response relationships, acute toxicity, and therapeutic index between the alkaloid extract of Mitragyna speciosa and its main active compound mitragynine in mice. Drug Dev Res 74:23\u201330","journal-title":"Drug Dev Res"},{"issue":"4","key":"5418_CR42","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.drugpo.2012.09.004","volume":"24","author":"D Saingam","year":"2013","unstructured":"Saingam D, Assanangkornchai S, Geater AF, Balthip Q (2013) Pattern and consequences of krathom (Mitragyna speciosa Korth.) use among male villagers in southern Thailand: a qualitative study. Int J Drug Policy 24(4):351\u2013358","journal-title":"Int J Drug Policy"},{"key":"5418_CR43","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.physbeh.2017.03.014","volume":"174","author":"H Salmanzadeh","year":"2017","unstructured":"Salmanzadeh H, Azizi H, Semnanian S (2017) Adolescent chronic escalating morphine induce long lasting changes in tolerance and dependence to morphine in rats. Physio Behav 174:191\u2013196","journal-title":"Physio Behav"},{"key":"5418_CR44","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.pbb.2003.09.006","volume":"76","author":"G Schulties","year":"2003","unstructured":"Schulties G, Morse AC, Liu J (2003) Repeated experience with naloxone facilitates acute morphine withdrawal: potential role for conditioning processes in acute opioid dependence. Pharmacol Biochem Behav 76:493\u2013503","journal-title":"Pharmacol Biochem Behav"},{"key":"5418_CR45","doi-asserted-by":"crossref","first-page":"11427","DOI":"10.3390\/ijms130911427","volume":"13","author":"AR Shamima","year":"2012","unstructured":"Shamima AR, Fakurazi S, Hidayat MT, Hairuszah I, Moklas MA, Arulsevan P (2012) Antinociceptive action of isolated mitragynine from Mitragyna speciosa through activation of opioid receptor system. Int J Mol Sci 13:11427\u201311442","journal-title":"Int J Mol Sci"},{"key":"5418_CR46","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.drugalcdep.2014.03.017","volume":"139","author":"D Singh","year":"2014","unstructured":"Singh D, M\u00fcller CP, Vicknasingam BK (2014) Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users. Drug Alcohol Depend 139:132\u2013137","journal-title":"Drug Alcohol Depend"},{"key":"5418_CR47","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.brainresbull.2016.05.004","volume":"126","author":"D Singh","year":"2016","unstructured":"Singh D, Narayanan S, Vicknasingam B (2016) Traditional and non-traditional uses of mitragynine (Kratom): a survey of the literature. Brain Res Bull 126:41\u201346","journal-title":"Brain Res Bull"},{"key":"5418_CR48","doi-asserted-by":"crossref","unstructured":"Singh D, Narayanan S, Vicknasingam B, Corazza C, Santacroce R, Roman-Urrestarazu A (2017) Changing trends in the use of kratom (Mitragyna speciosa) in Southeast Asia. Hum Psychopharmacol Clin Exp:e2582","DOI":"10.1002\/hup.2582"},{"issue":"2","key":"5418_CR49","first-page":"41","volume":"26","author":"EJ Shellard","year":"1974","unstructured":"Shellard EJ (1974) The alkaloids of Mitragyna with special reference to those of Mitragyna speciosa Korth. Bull Narc 26(2):41\u201355","journal-title":"Bull Narc"},{"key":"5418_CR50","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1460-9592.2004.01264.x","volume":"14","author":"DC Stoller","year":"2004","unstructured":"Stoller DC, Smith FL (2004) Buprenorphine blocks withdrawal in morphine-dependent rat pups. Pediatr Anesth 14:642\u2013649","journal-title":"Pediatr Anesth"},{"issue":"3","key":"5418_CR51","first-page":"21","volume":"27","author":"S Suwanlert","year":"1975","unstructured":"Suwanlert S (1975) Study of kratom eaters in Thailand. Bull Narc 27(3):21\u201327","journal-title":"Bull Narc"},{"issue":"5","key":"5418_CR52","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1080\/02791072.2015.1096434","volume":"47","author":"MT Swogger","year":"2015","unstructured":"Swogger MT, Hart E, Erowid F, Trabold N, Yee K, Parkhurst KA, Priddy BM, Walsh Z (2015) Experiences of kratom users: a qualitative analysis. J Psycho Drugs 47(5):360\u2013367","journal-title":"J Psycho Drugs"},{"key":"5418_CR53","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.drugalcdep.2017.10.012","volume":"183","author":"MT Swogger","year":"2018","unstructured":"Swogger MT, Walsh Z (2018) Kratom use and mental health: a systematic review. Drug Alcohol Depend 183:134\u2013140","journal-title":"Drug Alcohol Depend"},{"key":"5418_CR54","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1021\/jm010576e","volume":"45","author":"H Takayama","year":"2002","unstructured":"Takayama H, Ishikawa H, Kurihara M, Kitajima M, Aimi N, Ponglux D, Koyama F, Matsumoto K, Moriyama T, Yamamoto LT, Watanabe K, Murayama T, Horie S (2002) Studies on the synthesis and opioid agonistic activities of mitragynine-related indole alkaloids: discovery of opioid agonists structurally different from other opioid ligands. J Med Chem 45:1949\u20131956","journal-title":"J Med Chem"},{"key":"5418_CR55","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0024-3205(98)00075-7","volume":"62","author":"S Thongpradichote","year":"1998","unstructured":"Thongpradichote S, Matsumoto K, Tohda M, Takayama H, Aimi N, Sakai S, Watanabe H (1998) Identification of opioid receptor subtypes in antinociceptive actions of supraspinally-administered mitragynine in mice. Life Sci 62:1371\u20131378","journal-title":"Life Sci"},{"key":"5418_CR56","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/bph.13435","volume":"173","author":"DA Thorn","year":"2016","unstructured":"Thorn DA, Zhang Y, Li J (2016) Effects of the imidazoline I2 receptor agonist 2-BFI on the development of tolerance to and behavioural\/physical dependence on morphine in rats. Br J Pharmacol 173:1363\u20131372","journal-title":"Br J Pharmacol"},{"issue":"3","key":"5418_CR57","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1016\/0014-2999(95)00360-W","volume":"280","author":"K Tsou","year":"1995","unstructured":"Tsou K, Patrick SL, Walker JM (1995) Physical withdrawal in rats tolerant to \u03949-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist. Eur J Pharmacol 280(3):R13\u2013R15","journal-title":"Eur J Pharmacol"},{"key":"5418_CR58","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jep.2011.04.011","volume":"136","author":"Z Utar","year":"2011","unstructured":"Utar Z, Majid MI, Adenan MI, Jamil MF, Lan TM (2011) Mitragynine inhibits the COX-2 mRNA expression and prostaglandin E (2) production induced by lipopolysaccharide in RAW264.7 macrophage cells. J Ethnopharmacol 136:75\u201382","journal-title":"J Ethnopharmacol"},{"key":"5418_CR59","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s00213-001-0969-y","volume":"160","author":"SA Varvel","year":"2002","unstructured":"Varvel SA, Vann RE, Wise LE, Philibin SD, Porter JH (2002) Effects of antipsychotic drugs on operant responding after acute and repeated administration. Psychopharmacology 160:182\u2013191","journal-title":"Psychopharmacology"},{"key":"5418_CR60","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.drugpo.2009.12.003","volume":"21","author":"B Vicknasingam","year":"2010","unstructured":"Vicknasingam B, Narayanan S, Beng GT, Mansor SM (2010) The informal use of ketum (Mitragyna speciosa) for opioid withdrawal in the northern states of peninsular Malaysia and implications for drug substitution therapy. Int J Drug Policy 21:283\u2013288","journal-title":"Int J Drug Policy"},{"issue":"4","key":"5418_CR61","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJMra1511480","volume":"374","author":"ND Volkow","year":"2016","unstructured":"Volkow ND, Koob GF, McLellan AT (2016) Neurobiologic advances from brain disease model of addiction. N Engl J Med 374(4):363\u2013371","journal-title":"N Engl J Med"},{"key":"5418_CR62","unstructured":"Watanabe K, Yano S, Horie S, Yamamoto LT, Sakai S, Takayama H, Ponglux D, Wongseripipatan S (1992) Pharmacological profiles of \u2018kratom\u2019 (Mitragyna speciosa), a Thai medical plant with special reference to its analgesic activity. In: Tongroach P, Watanabe H, Ponglux D, Suvanakoot U, Ruangrungsi N (Eds.). Adv Res Pharmacol Act Subst Nat Prod 125-132"},{"key":"5418_CR63","unstructured":"Watanabe K, Yano S, Horie S, Yamamoto LT, Takayama H, Aimi H, Sakai S, Ponglux D, Tongroacj P, Shan J, Pang PKT (1999) Pharmacological properties of some structurally related indole alkaloids contained in the Asian herbal medicines, hirsutine and mitragynine, with special reference to their Ca2+ antagonistic and opioid-like effects. In: Watanabe, H., Shibuya, N.R., Farnsworth, N.R. (Eds.). Pharmacol Res Tradit Herb Med 11:163\u2013177"},{"issue":"10","key":"5418_CR64","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1007\/s00213-018-4974-9","volume":"235","author":"K Yue","year":"2018","unstructured":"Yue K, Kopajtic TA, Katz JL (2018) Abuse liability of mitragynine assessed with a self-administration procedure in rats. Psychopharmacology 235(10):2823\u20132829","journal-title":"Psychopharmacology"},{"issue":"1","key":"5418_CR65","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/adb.12185","volume":"21","author":"NH Yusoff","year":"2016","unstructured":"Yusoff NH, Suhaimi FW, Vadivelu RK, Hassan Z, R\u00fcmler A, Rotter A, Amato D, Dringenberg HC, Mansor SM, Navaratnam V, M\u00fcller CP (2016) Abuse potential and adverse cognitive effects of mitragynine (kratom). Addict Biol 21(1):98\u2013110","journal-title":"Addict Biol"},{"key":"5418_CR66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2017.05.059","volume":"332","author":"NH Yusoff","year":"2017","unstructured":"Yusoff NH, Mansor SM, M\u00fcller CP, Hassan Z (2017) Opioid receptors mediate the acquisition, but not the expression of mitragynine-induced conditioned place preference in rats. Behav Brain Res 332:1\u20136","journal-title":"Behav Brain Res"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-019-05418-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-019-05418-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-019-05418-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T00:21:48Z","timestamp":1607646108000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-019-05418-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,12]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["5418"],"URL":"https:\/\/doi.org\/10.1007\/s00213-019-05418-6","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,12]]},"assertion":[{"value":"26 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The experiments were conducted within the bounds of local ethical regulations and were carried out in accordance with the guidelines for the use of experimental animals and approved by the Animal Ethics Committee, Universiti Sains Malaysia (AECUSM).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}